Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.
Metrics to compare | WINL | Peers Peers - average of corresponding metrics from companies closely matching WINL: VIMTALABS, SYNGENE, INNOVACAP, AKUMS, AJANTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWINLPeersSector |
---|---|---|---|---|
P/E Ratio | 38.4x | 43.9x | −0.7x | |
PEG Ratio | 1.17 | 0.29 | 0.00 | |
Price/Book | 5.0x | 6.0x | 2.6x | |
Price / LTM Sales | 3.4x | 6.3x | 3.2x | |
Upside (Analyst Target) | - | 1.3% | 43.2% | |
Fair Value Upside | Unlock | −19.8% | 6.8% | Unlock |